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Abstract Killer cell immunoglobulin-like receptors (KIR)
gene frequencies vary between populations and contribute
to functional variation in immune responses to viruses,
autoimmunity and reproductive success. This study
describes the frequency distribution of 12 variable KIR
genes and their HLA-C ligands in two Iranian populations
who have lived for many generations in different environ-
ments: the Azerbaijanis at high altitude and the Jonobi
people at sea level. The results are compared with those
published for other human populations and a large group of
English Caucasians. Differences were seen in KIR and
HLA-C group frequencies, in linkage disequilibrium and
inhibitory/activating KIR ratios between the groups. Simi-
larities with geographically close populations in the
frequencies of the KIR A and B haplotypes and KIR AA
genotype reflected their common ancestry. The extreme
variability of the KIR gene family and their HLA-C ligands
is highlighted and their importance in defining differences
between geographically and culturally isolated communities
subject to different environmental pressures who come
from the same ethnic grouping.
Keywords KIR.HLA-C.Genotyping.Iranian.
Azerbaijanis.Jonobi
Introduction
Natural killer (NK) cells are essential components of the
innate immune system and act in the first line of defence
against infection, play a role in tumour surveillance and are
involved in placental development. Functionally, they are
controlled by activating and inhibitory receptors (Colucci et
al. 2003; Lanier 2008; McQueen and Parham 2002) and in
humans the Killer cell Immunoglobulin-like Receptors
(KIR) are of central importance in distinguishing normal
healthy self cells from diseased or allogeneic targets. HLA
class I molecules are ligands for some of the KIR and can
trigger signals to inhibit effector function of the NK cells or
conversely to stimulate killing or cytokine production
(Colonna et al. 2000; Long et al. 2001). The KIR genes
and the genes for their HLA class I ligands reside on
different chromosomes and probably constitute the most
diverse loci in the human genome. Indeed, the KIR region is
clearly undergoing rapid evolution and selection and only
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genotypes (Khakoo et al. 2000; Parham 2005; Shilling et al.
2002). The diversity of the KIR region is achieved by both
polymorphism at individual KIR gene loci as well as
variable gene content. The framework KIR genes (3DL3,
2DL4 and 3DL2) are present in nearly all individuals.
Thirteen additional KIR genes have been characterised
encoding five inhibitory receptors (3DL1, 2DL1–3 and
2DL5) and six activating KIR (2DS1–5, 3DS1). There are
also two pseudogenes (2DP1 and 3DP1) that encode no cell
surface receptors. Although KIR genotypes can vary
markedly, these can be simplified into two broad categories
comprised of A and/or B haplotypes. The simpler A
haplotype has 7 KIR genes mainly coding for the inhibitory
type (3DL1–3, 2DL1 and 2DL3) and a single KIR gene,
2DS4, coding for an activating receptor. KIR2DS4 is
frequently represented by alleles with a frame-shifting
deletion that abrogates the activating function of the
receptor. The B haplotype has a more variable content with
additional KIR genes (2DS1–3, 2DS5, 3DS1, 2DL2 and
2DL5) chiefly coding for activating receptors. In addition,
the B haplotype can be divided into two halves, which are
centromeric or telomeric to the centrally placed framework
locus, 2DL4 (Yawata et al. 2002). These two halves were
deduced from linkage disequilibrium studies and appear to
be under differing selection pressures (Yawata et al. 2006).
Similarly the numerous HLA-C alleles fall into one of two
categories, C1 and C2, as recognized by the NK cell
through the KIR receptors.
A number of studies of human populations world-wide
have shown differences in KIR frequencies and haplotypes
correlating with ethnicity, migration routes out of Africa
and relative population isolation (Denis et al. 2005;
Gendzekhadze et al. 2006; Kulkarni et al. 2008; Norman
et al. 2002; Rajalingam et al. 2008; Rayes et al. 2008;
Single et al. 2007). In the Middle East, the KIR
frequencies are similar to those found in Caucasian
populations whilst KIR genotypes in Indians or Pakistanis
show a tendency towards an increase in KIR B haplotypes.
Interestingly, the Parsis who migrated from Persia to
North India over 1,000 years ago differ from their North
Indian neighbours but show close similarities to KIR
genotypes in Maharashtrians who settled in North India in
ancient times and have their own language (Kulkarni et al.
2008). Until recently there had been no data available for
Iranian populations which left a gap, geographically
speaking, between the near-East (Mahfouz et al. 2006;
Rayes et al. 2008) and Pakistan and India (Kulkarni et al.
2008;N o r m a ne ta l .2002; Rajalingam et al. 2002)i n
reported KIR variation.
We have now genotyped samples from two distinct
Iranian populations the Azerbaijanis and the Jonobi people
and compared our results with those populations that are
geographical neighbours as well as an English Caucasian
group. The Azerbaijanis have lived for many generations at
high altitude (above 2,400 m) in East Azerbaijan and
Ardabil provinces. The Jonobi people from Hormozgan
province and Balochistan live at sea level along the shores
of the Persian Gulf and Oman Sea (Fig. 1). In epidemio-
logical studies, KIR and HLA ligand combinations have
been shown to be important in the pathogenesis of certain
viral infections such as HIVand HCV (Khakoo et al. 2004;
Martin et al. 2002), in autoimmune diseases (Gardiner
2008; Nelson et al. 2004) and in reproductive fitness (Hiby
et al. 2004, 2008; Parham 2004). We therefore typed our
two Iranian populations for the12 KIR genes characterised
by their variable presence and also identified the HLA-C
groups, KIR ligands C1 and C2, carried by each individual.
The Iranian results were compared to our Caucasian
population and to other geographically close populations
described in the literature.
Materials and methods
Study subjects
Blood samples were collected from unrelated adult males
from two isolated Iranian communities as described
(Ashrafian-Bonab et al. 2007). Marrying out of these
communities is not common practice and they are very
Fig. 1 Ethnographic regions of Iran showing the two populations
genotyped for KIR and HLA-C groups. Borders in the figure roughly
correspond to cultural regions based on ethnicity and language. From
Ashrafian-Bonab et al. 2007. Azerbaijanis traditionally live at
>2,400 m, the Jonobi live at sea level in the Hormozgan and
Baluchistan provinces
66 Immunogenetics (2010) 62:65–73different in terms of culture and language. Samples were
randomly collected from consenting volunteers to ensure an
unbiased sampling strategy. Ethnic information was
obtained on the place of birth of the subject and the place
of birth of their parents and grandparents (Ashrafian-Bonab
et al. 2007). One hundred samples from both populations
were analysed in this study. Ethical approval was obtained
from the Iranian Ministry of Health and the Iranian Cultural
Heritage Organization.
Blood samples were taken from 584 healthy English
Caucasian primiparous women and their male partners.
Informed written consent and Local Ethics Committees'
approval were obtained.
DNA isolation and genotyping
DNA from the Iranian samples was extracted using the
PAXgene blood DNA kit (Preanalytix, GmbH, Germany).
Genomic DNA from the Caucasian cohort was isolated
from 5 ml of blood using the QIAamp DNA Maxi Blood
Kit (Qiagen, Crawley, UK). PCR-SSP was used to amplify
the genomic DNA for presence or absence of the 12
variable KIR genes coding for the inhibitory KIR, 2DL1,
2DL2, 2DL3, 2DL5 and 3DL1 and the activating KIR,
2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DS1 and the pseudo-
gene, 2DP1. KIR2DS4 alleles were also identified as being
of the full-length type or having the 22bp deletion that
would negate cell-surface expression, sometimes referred to
as KIR1D. Two pairs of PCR primers were selected for each
gene or allele to give relatively short amplicons of 100 to
800bp as previously described (Hiby et al. 2004). HLA-C
was also genotyped as group C1 and/or group C2 as
recognised by NK cells through the KIR receptors. The
method used to define these groups by PCR-SSP was as
previously described (Hiby et al. 2008).
Data analysis and statistical methods
Carrier frequency was calculated by direct counting of
individuals possessing at least one copy of the gene
(individuals heterozygous for a KIR gene cannot be
distinguished from those that are homozygous without
family members, who were not available for this study).
KIR gene frequency estimates were calculated using the
equation KGF ¼ 1  
p
1   f ðÞ where f is the carrier
frequency. Frequency of A and B haplotypes was deduced
by defining the A haplotype as having the variable genes
2DL1-2DL3-3DL1-2DS4 only. The presence of the B
haplotype would then be recognised by detection of any
of the other KIR genes. Fisher's exact test was used to
calculate p values for the comparison of carrier frequencies.
LD coefficients for two-locus associations were calculated
for unrelated Azerbaijani and Jonobi individuals according
to Imanishi et al. (1991). The statistical significance of LD
was calculated using Fisher's exact test. KIR2DL2/2DL3
and KIR3DL1/3DS1 allelic pairs and the HLA-C groups,
C 1a n dC 2 ,w e r ef o u n dt ob ei nH a r d y –Weinberg
equilibrium in all three populations.
Results and discussion
KIR and HLA-C group carrier frequencies
Only those KIR genes (n=12) that were known to have
variable occurrence were typed and thus a measure of gene
content could be obtained for each individual. The
framework genes, KIR3DL3, 3DL2, and 2DL4 as well as
the pseudogene 3DP1were assumed to be present in all
individuals as seen for most other populations. Carrier and
estimated gene frequencies are given in Table 1 together
with KIR frequencies from geographically close popula-
tions taken from the literature and from our English
Caucasian cohort. The prevalence of the most common
KIR AA genotype and that of the HLA-C2 group is also
given.
Notably, there were higher frequencies of a number of
KIR; both those coding for inhibitory receptors, KIR2DL1
and KIR3DL1 and activating receptors, KIR2DS1, 2DS4
and 3DS1 in the Azerbaijanis compared with the Jonobi
population. The genes coding for activating KIR, 2DS1 and
3DS1 are in strong linkage disequilibrium to each other and
have been implicated in resistance to infection and in
reproductive success (Hiby et al. 2008; Martin et al. 2002;
Qi et al. 2006). The KIR2DS4 allele coding for the full-
length cell surface receptor was present at equal frequency
in the two populations (carrier frequency being 29% in
Azerbaijanis, 28% in Jonobis, not shown), the deleted form
was more frequent in the Azerbaijanis. Expression of
inhibitory KIR has been shown to be important in
determining the responsiveness of NK cells to stimuli
(Anfossi et al. 2006; Yawata et al. 2008).
Overall the Jonobi population more closely resembled
the more westerly Palestinian and Lebanese people than
did the Azerbaijanis but neither had such high frequencies
of the activating KIR genes as seen in the more easterly
populations of the Karachi South Asians and the Parsis.
Notably KIR2DS3 was present at high frequency in both
Iranian populations (42% carriers) compared to our Caucasian
population (30% carriers). This relatively high frequency of
2DS3 was also observed for neighbouring population groups
from Palestine (Norman et al. 2001) to the Parsis in India
(Kulkarni et al. 2008).
The KIR A and B haplotypes were deduced from the
individual KIR gene frequencies as described. Overall there
was a balance in the frequencies of the A and B haplotypes
Immunogenetics (2010) 62:65–73 67T
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68 Immunogenetics (2010) 62:65–73as has been reported in all populations analysed (Rajalin-
gam et al. 2008). The Jonobi people had 56% A haplotypes
and the Azerbaijanis, 53%. Our Caucasian population had
59% A haplotypes to 41% B haplotypes. From the ratio of
frequencies of inhibitory (2DL1, 2DL2, 2DL3, 3DL1)t o
activating (2DS1, 2DS2, 2DS4 full length, 3DS1) KIR
genes reported to have HLA class I ligands the Azerbaijanis
are deviated more towards activation (ratio inhibitory to
activating KIR 1.85/1) than the Jonobi people (ratio 2.01/1).
The Caucasians gave a ratio with these KIR very similar to
the Jonobi population of 2.04/1.
In addition there was a significantly higher frequency of
the KIR ligand HLA-C2 in the Jonobis as compared to the
Azerbaijanis (p value, 0.006) and the Caucasians (p<0.001)
with a notably high carrier frequency of 57% (Table 1). The
C2 frequency is also high in Parsis (47%). In addition, the
data from our three populations fits well with the model of
Single et al. (2007) who depicted a negative correlation
between KIR2DS1 and its ligand HLA-C2 that provides
good evidence for their co-evolution (Fig. 2).
Since writing this report, two publications on other
Iranian populations have been released (Ashouri et al. 2009
and Tajik et al. 2009). One reported on the general Iranian
population selected from a number of cities (Tajik et al.
2009) and the second includes an Azeri population that was
not selected on living at high altitude and indeed does not
resemble our own Azerbaijani population in terms of the
KIR frequencies (Ashouri et al. 2009). The possible
confounding effect of racial admixture was suggested for
this latter population by the authors.
KIR genotype profiles
The Azerbaijanis and Jonobi people shared 16 KIR
genotype profiles and 15 of these were also seen in the
Caucasian population (Fig. 3). The KIR AA genotype was
the most frequent in all three populations. The
Azerbaijanis had seven profiles that were not found in
the Jonobi people (five of these were seen in the
Caucasians). In addition, the Jonobi people possessed 12
profiles not found in the Azerbaijanis and only four of
these were seen in the Caucasians. The English Caucasian
population had an additional 18 KIR profiles that were not
seen in either Iranian population and these were uncommon
genotypes present in one to four individuals only. The
number of distinct profiles in the Azerbaijani, Jonobi and
Caucasians numbered 23, 28 and 43, respectively. This
would support the view that the Iranian populations were
from relatively isolated populations as seen with the Parsis
(19 profiles, Kulkarni et al. 2008) and in contrast to the
genetically diverse North Indians (47 profiles, Rajalingam et
al. 2002) and our Caucasian population (Shifman et al.
2003).
KIR A and B haplotypes
Unusual KIR genotypes, with all the KIR A haplotype genes
but with single additional genes of the B haplotype were
observed. In the Azerbaijani population, two individuals
possessed KIR2DS1 with the A haplotype genes but no other
Bh a p l o t y p eKIR. This has been observed in other
populations at low frequency (Kulkarni et al. 2008). Another
Azerbaijani individual had an additional KIR2DS2 with the
KIR A haplotype genes as reported in several Indian
populations (Rajalingam et al. 2008). In addition a single
Jonobi individual had the unusual combination of KIR AA
genotype genes with a KIR2DL5gene. This has not been
reported before.
The next most common genotype in the Azerbaijanis
after KIR AA comprised both an A haplotype and a B
haplotype which was characterised by presence of the,
mainly activating, telomeric group of KIR genes: 3DS1-
2DL5-2DS5-2DS1 (profile 2 shared, Fig. 3). This was in
contrast to the second most common in the Jonobi which
had the A haplotype loci together with the centromeric B
Fig. 2 Correlation between KIR2DS1 and C-group 2 frequencies.
Results for our populations are superimposed upon the global
distribution. Each coloured circle represents a distinct population,
with the colours identifying the geographic origin of the populations.
The solid line represents the estimated regression line (Single et al.
2007).The Iranian and Caucasian population data reported here fits
well with the study of Kulkarni et al. (2008) The activating KIR2DS1
shows a negative correlation with its HLA-C2 ligand although this did
not reach significance. Boxed letters denote our populations: C
Caucasian, A Azerbaijani and J Jonobi. For comparison, NI North
Indian, M Maharashtrian and P Parsis are also shown within the
diamonds
Immunogenetics (2010) 62:65–73 69haplotype genes 2DL2 and 2DS2 (profile 4 shared,
Fig. 3).
Linkage disequilibrium
Comparing linkage disequilibrium between pairs of KIR
genes in the two Iranian populations reflected their different
spread of KIR genotypes (Fig. 4). The Jonobi sample had
29 pairs of genes in significant positive or negative LD
compared with the Azerbijani with 22 and this can be
compared with the endogamous Parsis population with 39
pairs. The higher frequency of the KIR AA genotype in the
Jonobi people was reflected in a more marked distinction
between the LD values of the haplotype A and B KIR genes
seen for this population. There were 13 pairs of genes that
gave discordant results: eight pairs were in significant
negative LD only in the Jonobi (3DS1-3DL1, 2DL5-3DL1,
2DS5-3DL1, 2DS1-3DL1, 2DS4-3DS1, 2DS4-2DL5, 2DS4-
2DS5 and 2DS4-2DS1), whereas two pairs were in
significant positive LD (2DP1-2DL3 and 2DL1-2DL3).
Only three KIR gene pairs in the Azerbijani showed
significance differences not found in the Jonobi with 2DL3-
2DL5, 2DL3-2DS5 and 2DL3-2DS1 being in significant
negative LD. Like the Parsis the Azerbijanis also showed an
unusual lack of LD between KIR2DL3 and KIR2DL1 which
are closely linked on the A haplotype and are reported to be in
strong LD in all other published populations. The
KIR2DL1*004 allele that resides on the B haplotype is not
in LD with KIR2DL3 so this may explain the results obtained
if the Azerbaijanis possess an unusual high frequency of the B
haplotype 2DL1 alleles. KIR2DL1 allele typing would be
required to confirm this.
Summary
The two Iranian populations showed distinctive differences
in KIR and HLA-C group carrier and genotype frequencies.
Comparison with other genotyped populations to the west
and east of Iran can now be made using this data. We also
describe unusual KIR genotypes emphasising the great
diversity and malleability of the KIR locus in human
 KIR genes    Azerbaijani Jonobi  Caucasian 
Profiles    2DL1  2DL2 2DL3 2DL5 3DL1 2DS1 2DS2 2DS3 2DS4 2DS5 3DS1 n=100  n=100 n=584 
Profiles shared by Azerbaijanis and Jonobis  % %  (n) 
1AA                22  26  27.4  (160) 
2                  14 8  14.0  (82) 
3                 11  9  13.5  (79) 
4                     10  12  7.4  (43) 
5                      6 7 4.5  (26) 
6                    5 2  1.5  (9) 
7                     5 4  4.1  (24) 
8                    4 2  6.7  (39) 
9                   3 1  1.2  (7) 
10                   3  3  1.5  (9) 
11                  2 1  1.7  (10) 
12                   2 2  1.7  (10) 
13                  2 3  0.2  (1) 
14                 1 1  0.2  (1) 
15                  1 2  0.9  (5) 
16                  1 1  0.2(1) 
Profiles found in Azerbaijanis but not Jonobis      
1                 2  0  0 
2                 1 0  0.7  (4) 
3                 1 0  0.9  (5) 
4                    1  0  0 
5                   1 0  1.2  (7) 
6                 1 0  0.2  (1) 
7                1  0  0.2(1) 
Profiles found in Jonobis but not Azerbaijanis      
1               0  3  2.4  (14) 
2                0 2  0 
3                0 2  1.2  (7) 
4                       0  1  0 
5                     0  1  0 
6                  0 1  0 
7                 0 1  0 
8                0 1  0.3  (2) 
9                0 1  0 
10                     0 1  0 
11                   0 1  0.7  (4) 
12                  0  1  0 
                    
%
Fig. 3 KIR genotype profiles and frequencies for the two Iranian and an English Caucasian population. The Caucasian population had 18 unique
profiles not seen in the Iranian populations; these were uncommon genotypes present in one to four individuals (not shown here)
70 Immunogenetics (2010) 62:65–73populations that may arise from selective pressures in
response to pathogens, reproductive fitness or other
factors in the environment. Our other studies indicate
that KIR B telomeric genes are those lacking in Caucasian
women who experience problems during pregnancy. Of
particular interest in this regard are pregnancy and
reproduction at high altitude: birth weight decreases with
altitude and the risk of foetal growth restriction and pre-
eclampsia are increased (Julian et al. 2007; Zamudio
2007). Furthermore, these observations are likely due
directly to hypoxia at altitude, rather than economic status
( G i u s s a n ie ta l .2001). Importantly, those with high
altitude ancestry are partially protected from this reduc-
tion in fetal growth compared with those who have settled
in the area more recently (Julian et al. 2007). When
comparing these two Iranian populations for the two
polymorphic gene families the increased incidence of KIR
B telomeric genes in the Azerbaijanis compared to the
Jonobis is interesting because the incidence of hyperten-
sion in pregnancy and recurrent miscarriage is increased
in these Iranians living at high altitude in data supplied by
the Iranian Ministry of Health (Table 2). Whether differ-
ences in KIR can be ascribed to contrasting environments,
especially adaptations to living at high and low altitude,
can only be determined as data on other similar
populations increases.
 Azerbaijanis 
      2DS2 2DL2 2DL3 2DP1  2DL1  3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4
2DS2 ∆   0.218 -0.259  -0.065  -0.065 -0.112 0.018 0.101 0.131 0.009 0.027 -0.112 
 p   <0.001  <0.001  NS  NS  NS NS <0.001 <0.001 NS NS NS
           
2DL2 ∆     0.211  -0.265  -0.066  -0.066  -0.115 0.027 0.102 0.127 0.016 0.036 -0.115 
 p  <0.001   <0.001  NS  NS  NS NS <0.001 <0.001 NS NS NS
           
2DL3 ∆     -0.254 -0.263    0.060 0.060  0.031 -0.068 -0.240 -0.163 -0.070 -0.112 0.031 
 p  <0.001 <0.001    NS  NS  NS NS <0.001 <0.001 0.047 0.006 NS
           
2DP1 ∆     -0.114 -0.117  0.106   0.090  -0.017 -0.073 -0.060 0.024 -0.079 -0.071 -0.017 
 p  NS NS  0.003    0.01  NS NS NS NS NS NS NS
           
2DL1 ∆     -0.114 -0.117  0.106  0.143    -0.017 -0.073 -0.060 0.024 -0.079 -0.071 -0.017 
 p  NS NS  0.003  <0.001    NS NS NS NS NS NS NS
           
3DL1 ∆     0.027 0.044 -0.102  -0.046  -0.046  -0.126 -0.104 -0.132 -0.136 -0.124 0.143 
 p  NS NS  NS NS  NS  NS NS NS NS NS <0.001
           
3DS1 ∆     0.018 0.000  0.009 0.036  0.036 -0.210 0.163 0.054 0.134 0.173 -0.126
 p  NS NS  NS NS  NS  <0.001 <0.001 0.015 <0.001 <0.001 NS
           
2DL5 ∆     0.106 0.092 -0.066 0.066  0.066 -0.163 0.127 0.143 0.128 0.155 -0.104
 p  <0.001 <0.001  NS  NS  NS  0.042 <0.001 <0.001 <0.001 <0.001 NS
           
2DS3 ∆     0.125 0.124 -0.095 0.041  0.041 -0.028 0.051 0.147 0.000 0.048 -0.132 
 p  <0.001 <0.001 0.01049  NS  NS  NS 0.0113 <0.001 NS 0.042 NS
           
2DS5 ∆     0.023 0.005 -0.027 0.035  0.035 -0.112 0.113 0.123 0.015 0.145 -0.136 
 p  NS NS  NS NS  NS  0.00831 <0.001 <0.001 NS <0.001 NS
           
2DS1 ∆     0.030 0.013 -0.030 0.041  0.041 -0.201 0.130 0.147 0.044 0.132 -0.124 
 p  NS NS  NS NS  NS  0.002 <0.001 <0.001 0.03983 <0.001 NS
           
2DS4 ∆     0.027 0.044 -0.102  -0.046  -0.046  0.195 -0.210 -0.163 -0.028 -0.112 -0.201
 p  NS NS  NS NS  NS  <0.001 <0.001 0.042 NS 0.00831 0.002
      Jonobis                         
Fig. 4 Linkage disequilibrium
analysis for 12 KIR genes in
Azerbaijanis and Jonobi people.
LD coefficients (empty triangle)
and p values (p) on the upper
triangle are for the Azerbaijanis.
Values on the lower triangle are
for the Jonobis. NS not
significant
Table 2 Reproductive problems in the two Iranian populations (data from the Iranian Ministry of Health)
Geographical area East Azerbaijan and Ardabil Hormozghan and Baluchistan
Population Azerbaijanis Jonobi
Recurrent miscarriage or late pregnancy miscarriage 5.3% 3.2%
Low birth weight<2,500 g 6.9% 6.7%
Hypertension 12.5% 6.8%
Blurred vision and headache due to hypertension 4.9% 2.3%
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